Von Willebrand disease. Coordination between levels of healthcare
DOI:
https://doi.org/10.60103/phc.v27.e879Keywords:
von Willebrand Diseases; Blood Coagulation Disorders; Intersectoral CollaborationAbstract
Introduction: Von Willebrand disease (VWD), the most common congenital bleeding disorder, requires coordinated care between primary care and coagulation referral unit to ensure proper diagnosis and safe pharmacotherapeutic management in these patients. Objective: to study the concordance between primary care and specialised care records, and to correct the discrepancies found.
Method: A two-phase study was performed. Phase 1: review of diagnostic and treatment records for patients with VWD registered on September 1, 2023 in a coagulation unit. Diagnoeis, prescription of bleeding-risk drugs, and history of bleeding in Primary Care setting were analysed. Phase 2 (October 2023–October 2024): primary care was contacted to correct inaccurate information and adjust treatments.
Results: A total of 106 patients (59% female, mean age 37.6 years) were included. A diagnosis of VWD was recorded in PC in 64.2%, vague diagnoses in 15.1% and 20.7% were not recorded. Eight patients (7.55%) were prescribed non-selective NSAIDs (three with no recorded diagnosis in Primary Care). After intervention by telephone or e-mail, discrepancies were reduced by 32.7% (from 35.8% to 3.1%), but the lack of a two-way telematic and protocolised communication system between care levels prevented reaching 0%.
Conclusions: Improved communication between levels of care reduced discrepancies, but systems need to be put in place to overcome organisational and logistical barriers to communication between professionals in the interest of patient safety.
Downloads
References
Batlle J, Perez-Rodriguez A, Pinto JC, Fraga EL, Rodriguez-Trillo Tch A, Fernanda Lopez-Fernandez M. Diagnosis and management of von Willebrand disease in Spain. Semin Thromb Hemost. 2011;37(5):503–10. doi: 10.1055/s-0031-1281036.
Fogarty H, Doherty D, O’Donnell JS. New developments in von Willebrand disease. Br J Haematol. 2020;191(3):329–39. DOI: 10.1111/bjh.16681.
Weyand AC, Flood VH. Von Willebrand Disease: Current Status of Diagnosis and Management. Hematol Oncol Clin North Am. 2021; 35(6):1085–101. doi: 10.1016/j.hoc.2021.07.004.
Colonne CK, Reardon B, Curnow J, Favaloro EJ. Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations. J Blood Med. 2021;12:755–68. doi: 10.2147/JBM.S266791.
Govorov I, Ekelund L, Chaireti R, Elfvinge P, Holmström M, Bremme K, et al. Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand’s disease. Exp Ther Med. 2016 May;11(5):1923–9. doi: 10.3892/etm.2016.3144.
VanderMeulen H, Arya S, Nersesian S, Philbert N, Sholzberg M. What have we learned about the patient’s experience of von Willebrand disease? A focus on women. Hematol Am Soc Hematol Educ Progr. 2022;2022(1):631–6. doi: 10.1182/hematología.2022000391.
Merz LE, AbdelHameid D, Kanaan DM, Farah S, Manzo P, Connell NT. Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease. Blood Adv. 2024;8(9):2244–7. doi: 10.1182/bloodadvances.2023012348.
Driver B, Marks DC, van der Wal DE. Not all (N)SAID and done: Effects of nonsteroidal anti-inflammatory drugs and paracetamol intake on platelets. Res Pract Thromb Haemost. 2020 Jan;4(1):36–45. DOI: 10.1002/rth2.12283.
Naharro Máñez AM, Tárraga López PJ. Innovando en gestión asistencial: análisis del modelo de integración primaria, especializada y sociosanitaria. Med Gen y Fam (edición Digit [Internet]. 2016;5(4):149–54. Available from: https://www.elsevier.es/es-revista-medicina-general-familia-edicion-digital--231-articulo-innovando-gestion-asistencial-analisis-del-S1889543316300081
Allepuz A, Gallardo C, Perona M. Coordinación entre niveles asistenciales: ¿qué priorizan los profesionales? Atención Primaria [Internet]. 2012;44(9):568–9. Available from: https://www.elsevier.es/es-revista-atencion-primaria-27-articulo-coordinacion-entre-niveles-asistenciales-que-S0212656712002065
Herrero Domínguez-Berrueta MC, Muñoz-García M, Delgado-Silveira E, Martín-Aragón S, Gangoso Fermoso A. Primary care pharmacist-led medication review in older adult patients in coordination with general practitioners: an observational retrospective cohorts study. Explor Res Clin Soc Pharm. 2023;13:100390. doi: 10.1016/j.rcsop.2023.100390.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jorge Esquivel Negrín, María Isabel Peris Fernaud, María Ángeles Ocaña Gómez, Mario Ríos De Paz, María Dolores De Dios García

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).



